Literature DB >> 27108009

Reference values of MostGraph measures for middle-aged and elderly Japanese individuals who participated in annual health checkups.

Yuki Abe1, Yoko Shibata2, Akira Igarashi3, Sumito Inoue4, Kento Sato5, Masamichi Sato6, Takako Nemoto7, Maki Kobayashi8, Michiko Nishiwaki9, Tomomi Kimura10, Yoshikane Tokairin11, Takamasa Kayama12, Isao Kubota13.   

Abstract

BACKGROUND: The forced oscillation technique (FOT) can measure respiratory system resistance and reactance under tidal volume respiration. MostGraph is a device that incorporates the FOT and enables the immediate, three-dimensional visualization of resistance and reactance parameters. The aim of this study was to establish MostGraph reference values for middle-aged and elderly Japanese individuals.
METHODS: From 2004 to 2006, 3253 subjects living in Takahata, Yamagata underwent spirometry. Of these, 872 again underwent spirometry in 2011, and 784 (368 men, ages 46-89 years; 416 women, ages 47-90 years) underwent FOT examinations using MostGraph-01.
RESULTS: In this study population, 19.0% of the men and 91.5% of the women were life-long never smokers. Abnormal spirometric findings were observed in 30.2% of the men and 14.6% of the women. Although the respiratory system resistance and reactance parameters obtained using MostGraph were not distributed normally, normal distribution was achieved via natural logarithm (R5, R20, Fres, and ALX), square root (R5-R20), or exponential (X5) transformation. Furthermore, the transformed values were converted back to the actual values after determining the values representing one and two standard deviations from the mean.
CONCLUSION: Respiratory system resistance and reactance reference values were determined using MostGraph in middle-aged and elderly Japanese individuals who participated in annual health checkups.
Copyright © 2016 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Forced oscillation technique; MostGraph; Reference value; Respiratory system resistance and reactance; Yamagata–Takahata study

Mesh:

Year:  2016        PMID: 27108009     DOI: 10.1016/j.resinv.2015.12.004

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  5 in total

1.  Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?

Authors:  Masato Muraki; Kyuya Gose; Soichiro Hanada; Hirochiyo Sawaguchi; Yuji Tohda
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

2.  Use of the forced-oscillation technique to estimate spirometry values.

Authors:  Shoichiro Yamamoto; Seigo Miyoshi; Hitoshi Katayama; Mikio Okazaki; Hisayuki Shigematsu; Yoshifumi Sano; Minoru Matsubara; Naohiko Hamaguchi; Takafumi Okura; Jitsuo Higaki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-03

3.  Prediction of Spirometric Indices Using Forced Oscillometric Indices in Patients with Asthma, COPD, and Interstitial Lung Disease.

Authors:  Seigo Miyoshi; Hitoshi Katayama; Minoru Matsubara; Takahide Kato; Naohiko Hamaguchi; Osamu Yamaguchi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-01

4.  Perioperative changes in respiratory impedance in lobectomy and their clinical impact.

Authors:  Ryosuke Kaku; Makoto Yoden; Takuya Shiratori; Kazuki Hayashi; Keigo Okamoto; Yasuhiko Oshio; Yasutaka Nakano; Jun Hanaoka
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

5.  Examination of predictable factors of perioperative respiratory complications by preoperative forced oscillation technique parameters.

Authors:  Akira Igarashi; Sumito Inoue; Yoko Shibata; Keiko Nunomiya; Takahito Ota; Yu Ishibashi; Hiroaki Murano; Kodai Furuyam; Sujeong Yang; Hiroyoshi Machida; Hiroshi Nakano; Kento Sato; Masamichi Sato; Takako Nemoto; Michiko Nishiwaki; Keiko Yamauchi; Jun Suzuki; Mitsuaki Sadahiro; Masafumi Watanabe
Journal:  EXCLI J       Date:  2020-12-21       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.